Amniotic Skin Grafts
Chronic Wounds (Diabetic Ulcers, Venous Ulcers, Pressure Sores)
Key Facts
About Fusion Biologics
Fusion Biologics is a private, commercial-stage company leveraging human amniotic membrane to create biologic wound care products. Its core business involves processing and supplying sterile amniotic skin grafts directly to healthcare providers for the treatment of chronic wounds, burns, and surgical recovery. The company emphasizes product customization, regulatory compliance, and provider training as key differentiators. Operating from San Diego, it appears to be an early-revenue entity focused on penetrating the regenerative wound care market.
View full company profileAbout Fusion Biologics
Fusion Biologics is a private, commercial-stage company leveraging human amniotic membrane to create biologic wound care products. Its core business involves processing and supplying sterile amniotic skin grafts directly to healthcare providers for the treatment of chronic wounds, burns, and surgical recovery. The company emphasizes product customization, regulatory compliance, and provider training as key differentiators. Operating from San Diego, it appears to be an early-revenue entity focused on penetrating the regenerative wound care market.
View full company profileAbout Fusion Biologics
Fusion Biologics is a private, commercial-stage company leveraging human amniotic membrane to create biologic wound care products. Its core business involves processing and supplying sterile amniotic skin grafts directly to healthcare providers for the treatment of chronic wounds, burns, and surgical recovery. The company emphasizes product customization, regulatory compliance, and provider training as key differentiators. Operating from San Diego, it appears to be an early-revenue entity focused on penetrating the regenerative wound care market.
View full company profile